BC Cancer

BC Cancer Agency

poul sorenson, md phd - principal


kirk schultz, md - co-site lead

Dr. Kirk Schultz is a Professor at the University of British Columbia, BC Children’s Hospital Research Institute and a fellow of the Canadian Academy of Health Sciences. Dr. Schultz is a Pediatric Hematologist/Oncologist focused on new therapies and rejection in Blood and Marrow Transplantation (BMT) and immune therapy of blood cancers.Dr. Schultz is a past recipient of the CIHR/Wyeth Clinical Research Chair in Transplantation,past chair of the Pediatric BMT Consortium the largest children’s BMT clinical trials group inthe world, and president-elect of Cell Therapy and Transplantation Canada. He is currently the director of the Michael Cuccione Childhood Cancer Research Program group at the BC Children’s Hospital Research Institute.

mads daugaard, pHd - investigator


anne seino - program manager

rod rassekh, MD


Alberto delaidelli, MD phd - young investigator

Alberto Delaidelli is a young investigator at the BC Cancer Research Centre in Vancouver. He obtained his Medical Degree (MD) cum laude from the University of Milan (Italy) and his PhD from the University of British Columbia (Canada). His work focuses on the identification of optimal immunotherapy targets for the generation of effective cell-based therapies against pediatric brain tumours, and he has developed novel tests for a simplified and clinically tractable risk‑stratification of these tumours. In addition, he supports multiple members of the Dream Team with histopathological and molecular analyses of human and xenografted tissues. His work has been recognized with numerous awards, including a prestigious Killam Doctoral Scholarship and CIHR Fellowship.

rebecca deyell, md phd - young investigator


anne-chloe dhez, PhD - young investigator


htoo zarni Oo, MD - young investigator


Haifeng Zhang - young investigator

I was born and raised in Henan province, China. I studied bioengineering for my bachelor’s degree between 2004 and 2008 in Hebei University of Science and Technology, China. The same year after graduation, I moved to Shantou University Medical College, China, to study Molecular Biology and Biochemistry as a master’s student. That was when I started my research career in cancer biology (in esophageal cancer) under the supervision of Dr. En-Min Li and Dr. Li-Yan Xu. In 2010, two years into my master’s program, I was awarded a full PhD scholarship from the Li Ka Shing Foundation to pursue my PhD degree in University of Alberta, Edmonton, Canada. I continued my research in the pathobiology of esophageal cancer under the supervision of Dr. Raymond Lai, and I obtained my PhD degree in the summer of 2015. At the 2015 AACR meeting in Philadelphia, just a few months before getting my PhD, I interviewed with Dr. Poul Sorensen, and accepted a postdoctoral position at his laboratory in BC Cancer, Vancouver, Canada. Under the supervision of Dr. Sorensen, I am currently working on a SU2C project, i.e. Identification of IL1RAP as an oncoprotein and candidate immunotherapeutic target in Ewing sarcoma.